| abstract |
(57) [Summary] [Objective] To treat or prevent a patient having a condition associated with abnormal metabolism of acylcarnitine. [Structure] By orally or parenterally administering a preparation containing acylcarnitine or a pharmacologically acceptable salt thereof, symptoms due to abnormal metabolism of acylcarnitine are improved or prevented. The acylcarnitine is acetylcarnitine, propionylcarnitine, butyrylcarnitine, It may be isobutyrylcarnitine, valerylcarnitine, isovalerylcarnitine, hexanoylcarnitine, or the like. |